Columbia University/Herbert Irving Cancer Center ( Site 0009) — New York, New York

Columbia University/Herbert Irving Cancer Center ( Site 0009) is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University/Herbert Irving Cancer Center ( Site 0009) has participated in 1 clinical trials.

Therapeutic areas: Biliary Tract Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University/Herbert Irving Cancer Center ( Site 0009)?

Columbia University/Herbert Irving Cancer Center ( Site 0009) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University/Herbert Irving Cancer Center ( Site 0009) conducted?

Columbia University/Herbert Irving Cancer Center ( Site 0009) has 1 clinical trials on record. Their work covers Biliary Tract Carcinoma.

Is Columbia University/Herbert Irving Cancer Center ( Site 0009) accredited by Crixeo Health?

Columbia University/Herbert Irving Cancer Center ( Site 0009) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University/Herbert Irving Cancer Center ( Site 0009)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.